Form 4 for EBS Emergent BioSolutions Inc.
Accepted 2024-03-04 00:00:00 ET · period of report 2024-02-29 · accession 0001367644-24-000021 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-04 | 2024-02-29+ | EBS | LINDAHL RICHARD S | EVP, CFO | F - Tax | $3.24 | -9,721 | 158.7K | -6% | -$31.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-29 | F | D | 9,037 | $3.23 | 159,426 | D | — | — | (F1) Represents shares of common stock withheld to pay taxes. |
| 2 | Common | Common Stock | 2024-03-01 | F | D | 684 | $3.39 | 158,742 | D | — | — | (F1) Represents shares of common stock withheld to pay taxes. |